Trial Details
COMPLETEDBasic Information
| Clinical ID | c1201 |
|---|---|
| Identifier | NCT03798691 |
| Trial Title | Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Herpes Zoster |
| Interventions | BIOLOGICAL: Shingrix |
Participant Information
| Sponsor | University of Wisconsin, Madison |
|---|---|
| City | Madison |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2019-05-28 |
|---|---|
| Primary Completion Date | 2023-10-12 |
| Completion Date | 2024-09-10 |